Southville International School and Colleges
[177Lu-DOTA]0-D-Phe1-Tyr3-Octreotide (177Lu-DOTATOC) For Peptide Receptor Radiotherapy in Patients with Advanced Neuroendocrine Tumours: A Phase-II Study - Theranostics 2016 - 6:4

--Medical Technology--Medtech
Powered by Koha